What’s the problem?
August 24, 2017 – Centurion was notified by the U.S. Food & Drug Administration (FDA) regarding the potential contamination as they discovered this product may have been manufactured in a Pharmatech facility that was found to have a product that contained B. cepacia.
Affected products are Ninjacof Lot# 200N1601 (NDC 23359-032-16) and Ninjacof A with Lot# 201NA1601 (NDC 23359-033-16). The medicine is sold in 473 mL bottles with the expiration date of 11/2018.
Both products were distributed to the following states: Alabama, Arkansas, Florida, Georgia, Louisiana, Missouri, Mississippi, New Jersey, North Carolina, Ohio, Oklahoma, South Carolina, Tennessee, and Texas.
Centurion Labs is recommending that patients, pharmacies, and healthcare facilities stop use of affected Ninjacof products immediately.
To date, no B. cepacia infections or other adverse events have been reported in connection with the recall.
Do I Have a Ninjacof Recall Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Ninjacof lawsuits. We are handling individual litigation nationwide and currently accepting new B. cepacia infection cases in all 50 states.
Free Case Evaluation: Again, if you developed B. cepacia, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.